3 AIM shares I’d buy to hold for the next 10 years!

Our writer is looking for top stocks to buy outside the FTSE 100 and FTSE 250. Here’s a handful of AIM shares that have grabbed his attention.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’ve been scouring London’s Alternative Investment Market (AIM) for the best growth shares to buy. Here are three I’m considering buying for my investment portfolio in 2023.

CVS Group

The amount people spend on their pets has grown rapidly over the past decade. And it’s tipped to keep growing strongly even as the cost-of-living crisis endures. Analysts at Statista think the veterinary care market, for example, will expand at a compound annual growth rate of 8.46% between 2023 and 2027.

CVS Group (LSE:CVSG) is a UK share I’ve bought to capitalise on this theme. And I’m thinking about adding to my holdings following recent share price weakness. This business owns more than 500 vet surgeries across the country along with diagnostics centres and crematoria.

Latest financials showed organic sales rose 7.4% in the four months to October. This was at the top end of the company’s 4-8% target. I’d buy CVS even though labour shortages in the animalcare market could dent its growth plans.

Lok’nStore Group

Britain’s self-storage market could slow in the near term as the housing market cools. A need for temporary storage by home movers is the chief driver is this fast-growing industry.

But the long-term outlook remains robust, thanks to themes like population growth and the rise of e-commerce. So I’m considering adding Lok’nStore Group (LSE:LOK) shares to my portfolio.

The company is one of the largest players in the industry and has ambitious expansion plans to turbocharge earnings over the next decade. It wants to open four new major stores in the 12 months to October. And its secured pipeline of 10 sites (as of July 2022) will increase its owned space by a whopping 44.1%.  

The UK self-storage industry looks set to remain undersupplied for years to come. So rental incomes (which hit record highs last year) should continue rising strongly. Average rents shot 9% higher last year, according to real estate services business Cushman Wakefield.

Jubilee Metals Group

The green energy revolution provides excellent opportunities for UK share investors. One stock I’m considering buying to capitalise on the climate change battle is Jubilee Metals Group (LSE:JLP).

This AIM business recovers platinum group metals (PGMs), copper, cobalt and other industrial commodities. These are all in high demand as electric vehicle sales soar and increasing amounts of metal are loaded into catalytic converters.

I think now is a great time to build a position in Jubilee Metals too. Successful copper production trials recently using direct leaching could open up fresh growth opportunities in Zambia. On top of this, the miner currently trades on a price-to-earnings (P/E) ratio of just 6.2 times.

I’d buy Jubilee despite the threat of oversupply in some of its markets. This could hit prices and consequently profits growth.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has positions in Cvs Group Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Value Shares

Investing Articles

Here’s the stunning BP share price forecast for 2025

The BP share price enters 2025 in poor shape, after a tricky year for energy stocks. Harvey Jones looks at…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Here’s how I’m finding bargain shares to buy for 2025!

Our writer takes a fairly simply approach when it comes to hunting for cheap shares to buy for his portfolio.…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Is the BP share price set for a 75% jump?

The highest analyst target for BP shares in 2025 is 75% above the current price. So should investors consider buying…

Read more »

Investing Articles

Where can the BAE Systems share price go in 2025? Let’s ask the experts

The BAE Systems share price has had a strong year in 2024, but it's started slipping back a bit as…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

What can Warren Buffett teach an investor with £1,000?

Although Warren Buffett’s a billionaire, his investing lessons can be applied to far more modest portfolios. Our writer explains some…

Read more »

Investing Articles

Analysts are saying the AstraZeneca share price looks cheap despite China turmoil

The AstraZeneca share price could be considerably undervalued according to analysts. Dr James Fox takes a closer look at the…

Read more »

Pink 3D image of the numbers '2025' growing in size
Investing Articles

1 FTSE 100 stock I expect to outperform in 2025

Can the integration of its big acquisition from 2022 finally lead Rentokil Initial to outperform the FTSE 100 next year?…

Read more »

Investing Articles

Here’s my FTSE 250 share index prediction for 2025

The FTSE 250 index of shares has endured disappointing growth in recent times. Could 2025 be the year that it…

Read more »